XML 20 R9.htm IDEA: XBRL DOCUMENT
v3.23.1

Revenue Recognition | 3 Months Ended
--- | ---
Mar. 31, 2023
Revenue Recognition [Abstract] |
Revenue Recognition | REVENUE RECOGNITION Our policies for recognizing sales have not changed from those described in our Annual Report on Form 10-K for 2022. We disaggregate our net sales by business and geographic location for each of our segments as we believe it best depicts how the nature, amount, timing and certainty of our net sales and cash flows are affected by economic factors. Beginning in the first quarter of 2023, we consolidated Other MedSurg and Neurotechnology into Endoscopy as Other MedSurg and Neurotechnology (primarily Sustainability Solutions) has been fully integrated into our Endoscopy business. Endoscopy includes sales related to Other of $81 and $69 for the three months 2023 and 2022. We have reflected these changes in all historical periods presented.
Net Sales by Business |  |  |  |  |
| Three Months |  |
| 2023 | 2022 |  |  |
MedSurg and Neurotechnology: |  |  |  |  |
Instruments | $ | 575 |  | $ | 528 |  |  |  |
Endoscopy | 698 |  | 607 |  |  |  |
Medical | 778 |  | 664 |  |  |  |
Neurovascular | 284 |  | 301 |  |  |  |
Neuro Cranial | 355 |  | 323 |  |  |  |
| $ | 2,690 |  | $ | 2,423 |  |  |  |
Orthopaedics and Spine: |  |  |  |  |
Knees | $ | 566 |  | $ | 464 |  |  |  |
Hips | 375 |  | 327 |  |  |  |
Trauma and Extremities | 769 |  | 685 |  |  |  |
Spine | 284 |  | 279 |  |  |  |
Other | 94 |  | 97 |  |  |  |
| $ | 2,088 |  | $ | 1,852 |  |  |  |
Total | $ | 4,778 |  | $ | 4,275 |  |  |  |
Net Sales by Geography |  |  |  |  |
| Three Months 2023 |  | Three Months 2022
| United States | International |  | United States | International
MedSurg and Neurotechnology: |  |  |  |  |
Instruments | $ | 450 |  | $ | 125 |  |  | $ | 414 |  | $ | 114 |
Endoscopy | 564 |  | 134 |  |  | 486 |  | 121 |
Medical | 612 |  | 166 |  |  | 525 |  | 139 |
Neurovascular | 118 |  | 166 |  |  | 110 |  | 191 |
Neuro Cranial | 289 |  | 66 |  |  | 264 |  | 59 |
| $ | 2,033 |  | $ | 657 |  |  | $ | 1,799 |  | $ | 624 |
Orthopaedics and Spine: |  |  |  |  |
Knees | $ | 416 |  | $ | 150 |  |  | $ | 345 |  | $ | 119 |
Hips | 236 |  | 139 |  |  | 202 |  | 125 |
Trauma and Extremities | 554 |  | 215 |  |  | 487 |  | 198 |
Spine | 212 |  | 72 |  |  | 200 |  | 79 |
Other | 61 |  | 33 |  |  | 72 |  | 25 |
| $ | 1,479 |  | $ | 609 |  |  | $ | 1,306 |  | $ | 546 |
Total | $ | 3,512 |  | $ | 1,266 |  |  | $ | 3,105 |  | $ | 1,170 |
Contract Assets and Liabilities On March 31, 2023 and December 31, 2022 contract assets recorded in our Consolidated Balance Sheets were not significant. Our contract liabilities arise as a result of consideration received from customers at inception of contracts for certain businesses or where the timing of billing for services precedes satisfaction of our performance obligations. This occurs primarily when payment is received upfront for certain multi-period extended service contracts. Our contract liabilities of $757 and $741 on March 31, 2023 and December 31, 2022 are classified within accrued expenses and other liabilities and other noncurrent liabilities within our consolidated balance sheets based on the timing of when we expect to complete our performance obligations.

X
- Definition The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -URI https://asc.fasb.org/topic&trid=49130388 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (b)(2) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 12 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 9 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 12 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 12 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 12 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 15 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 12 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045 + Details
Name: | us-gaap_RevenueFromContractWithCustomerTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueRecognitionAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration